Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
2.230
-0.060 (-2.62%)
At close: Jul 17, 2026, 4:00 PM EDT
2.240
+0.010 (0.45%)
After-hours: Jul 17, 2026, 7:54 PM EDT
Lipocine Market Cap
Lipocine has a market cap or net worth of $18.38 million as of July 17, 2026. Its market cap has increased by 8.15% in one year.
Market Cap
18.38M
Enterprise Value
-6.34M
1-Year Change
8.15%
Ranking
Category
Stock Price
$2.23
ChartMarket Cap Chart
Since March 21, 2014, Lipocine's market cap has decreased from $82.30M to $18.38M, a decrease of -77.66%. That is a compound annual growth rate of -11.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 18.40M | -58.74% |
| Dec 31, 2025 | 44.60M | 70.88% |
| Dec 31, 2024 | 26.10M | 76.35% |
| Dec 29, 2023 | 14.80M | -57.95% |
| Dec 30, 2022 | 35.20M | -59.77% |
| Dec 31, 2021 | 87.50M | -2.02% |
| Dec 31, 2020 | 89.30M | 811.22% |
| Dec 31, 2019 | 9.80M | -64.87% |
| Dec 31, 2018 | 27.90M | -61.73% |
| Dec 29, 2017 | 72.90M | 8.48% |
| Dec 30, 2016 | 67.20M | -71.53% |
| Dec 31, 2015 | 236.00M | 250.67% |
| Dec 31, 2014 | 67.30M | -18.23% |
| Mar 21, 2014 | 82.30M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CEL-SCI | 20.45M |
| Pluri | 20.07M |
| Cellectar Biosciences | 20.06M |
| Longeveron | 19.65M |
| Akari Therapeutics, | 19.27M |
| Allarity Therapeutics | 18.93M |
| Quince Therapeutics | 18.46M |
| Neuphoria Therapeutics | 18.46M |